Session Details

F119 Fractional Laser and Light-based Technologies

Mon, Mar 11, 3:30 PM - 12:00 AM
Room 6C
2 CME Available Forum
View Map

DESCRIPTION

This session is appropriate for experienced and potential users of fractional laser and light technologies. Specific treatment protocols will be outlined and tips to optimize clinical outcomes will be shared. The expert faculty will use evidence-based approaches to examine the strengths and weaknesses of current fractional technology. A review of fractionated laser skin resurfacing and rejuvenation in varying skin tones and conditions as well as a discussion of future technologic applications will provide the attendee with the latest advancements in the fields.

LEARNING OBJECTIVES

1.

Discuss the current indications, limitations, and potential for fractional laser, light-based and energy-based devices in dermatology.

2.

Identify possible side effects and complications of fractionated skin resurfacing and rejuvenation procedures and develop strategies to prevent and treat them.

3.

Identify where fully ablative resurfacing would be preferable to fractional resurfacing.

SCHEDULE

3:30 PM

Introduction

Roy G. Geronemus, MD, FAAD

3:35 PM

Fractional Lasers Overview

Roy G. Geronemus, MD, FAAD

3:55 PM

Laser Scar Revision: Fractional Technology and Combination Treatment

Jill S. Waibel, MD, FAAD

4:15 PM

Fractional Resurfacing in Skin of Color

Douglas Wu, MD, PhD, FAAD

4:35 PM

Non Laser Fractional Resurfacing and Rejuvenation

Jordan Victor Wang, MD, MBE, MBA, FAAD

4:55 PM

The Role of Non Fractional Lasers

Joel Lee Cohen, MD, FAAD

5:15 PM

Questions and Answers

DIRECTOR

Roy G. Geronemus, MD, FAAD

Roy G. Geronemus, MD, FAAD

SPEAKERS

Joel Lee Cohen, MD, FAAD

Joel Lee Cohen, MD, FAAD

Jill S. Waibel, MD, FAAD

Jill S. Waibel, MD, FAAD

Jordan Victor Wang, MD, MBE, MBA, FAAD

Jordan Victor Wang, MD, MBE, MBA, FAAD

Douglas Wu, MD, PhD, FAAD

Douglas Wu, MD, PhD, FAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Joel Lee Cohen, MD, FAAD

Acclaro Medical – Advisory Board(Grants/Research Funding); Accure Medical, LLC – Investigator(Stock Options); Allergan, Inc. – Consultant(Honoraria); BTL Industries – Investigator(Grants/Research Funding); Castle Biosciences – Investigator(Grants/Research Funding); Cutera, Inc. – Investigator(Grants/Research Funding); Cynosure-Lutronic – Investigator(Grants/Research Funding); EltaMD – Advisory Board(Honoraria); Galderma USA – Consultant(Honoraria), Investigator(Grants/Research Funding); InMode – Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Consultant(Honoraria); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Revision Skincare – Advisory Board(Honoraria); Swift arc ventures – Investigator(Grants/Research Funding); Veradermics – Investigator(Grants/Research Funding); Vydence – Advisory Board(Honoraria); Wontech – Advisory Board(Honoraria);

Roy G. Geronemus, MD, FAAD

Accure, Inc – Stockholder Private Company(No Compensation Received); AVAVA, Inc. – Investigator(No Compensation Received); Sciton Inc. – Investigator(No Compensation Received);

Jill S. Waibel, MD, FAAD

Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);

Jordan Victor Wang, MD, MBE, MBA, FAAD

Accure, Inc – Investigator(Grants/Research Funding); Alastin Skincare, Inc – Investigator(Grants/Research Funding); Allergan Aesthetics – Investigator(Grants/Research Funding); AVAVA, LLC – Investigator(Grants/Research Funding); Blossom Innovations, LLC – Investigator(Grants/Research Funding); Cynosure – Investigator(Grants/Research Funding); Cytrellis Biosystems, Inc – Investigator(Grants/Research Funding); Lutronic – Investigator(Grants/Research Funding); Novoxel – Investigator(Grants/Research Funding); Sofwave – Investigator(Grants/Research Funding); Soliton – Investigator(Grants/Research Funding); Solta Medical – Investigator(Grants/Research Funding);

Douglas Wu, MD, PhD, FAAD

No financial relationships exist with ineligible companies.